Charles River Laboratories International (CRL) Deferred Taxes (2009 - 2025)

Charles River Laboratories International's Deferred Taxes history runs 17 years deep, the most recent figure standing at -$60.2 million for Q4 2025.

• In Q4 2025, Deferred Taxes fell 45.2% year-over-year to -$60.2 million; the TTM figure through Dec 2025 stood at -$75.3 million (down 11.66% YoY), while the FY2025 annual figure was -$75.3 million, down 11.66% from the prior year.
• Deferred Taxes was -$60.2 million for Q4 2025 at Charles River Laboratories International, down from $25.9 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $25.9 million in Q3 2025 to a low of -$60.2 million in Q4 2025.
• Historically, Deferred Taxes has averaged -$12.7 million across 5 years, with a median of -$11.6 million in 2022.
• The sharpest annual moves came in 2021 and 2025: Deferred Taxes soared 477.25% in 2021, then tumbled 1829.18% in 2025.
• A 5-year view of Deferred Taxes shows it stood at -$10.2 million in 2021, then advanced by 6.71% to -$9.6 million in 2022, then slumped by 136.92% to -$22.7 million in 2023, then slumped by 82.94% to -$41.4 million in 2024, then sank by 45.2% to -$60.2 million in 2025.
• The last three Deferred Taxes figures came in at -$60.2 million (Q4 2025), $25.9 million (Q3 2025), and -$22.0 million (Q2 2025), per Business Quant data.